Treatment of young boys with Duchenne muscular dystrophy with the NF-kappa B inhibitor edasalonexent showed a slowing of disease progression as assessed by MRI and functional measures-MedSci.cn

Treatment of young boys with Duchenne muscular dystrophy with the NF-kappa B inhibitor edasalonexent showed a slowing of disease progression as assessed by MRI and functional measures

Finkel, R; Vandenborne, K; Sweeney, H; Finanger, E; Tennekoon, G; Shieh, P; Willcocks, R; Walter, G; Rooney, W; Forbes, S; Triplett, W; Yum, S; Mancini, M; MacDougall, J; Fretzen, A; Bista, P; Nichols, A; Donovan, J

NEUROMUSCULAR DISORDERS, 2019; 29 (): S208

科室
- - 订阅+
  - 更多科室
工具
服务